How forest conversion can harm dung beetles
Peer-Reviewed Publication
Updates every hour. Last Updated: 6-Jun-2026 06:15 ET (6-Jun-2026 10:15 GMT/UTC)
Researchers at the University of Würzburg have shown that dung beetles suffer in canopy openings that have been deliberately created to promote biodiversity. Rising temperatures are significantly exacerbating the problem.
Researchers from the NeuroAD group (Neuropathology of Alzheimer’s Disease) within the Department of Cell Biology, Genetics and Physiology at the University of Málaga, also affiliated with IBIMA–BIONAND Platform and CIBERNED, have made a pioneering breakthrough in the fight against this disease by identifying astrocytes as a promising cellular target for the development of future therapies.
A research team led by Universitat Autònoma de Barcelona (UAB) researcher David Reverter has discovered the molecular mechanism that describes in detail the process regulating cell division in bacteria, based on the binding of the MraZ protein to the dcw gene cluster. The research has been published in Nature Communications.
Many diseases are driven by proteins that are difficult or impossible to inhibit with conventional drugs. Instead of blocking their activity, an emerging therapeutic strategy aims to remove these proteins entirely from the cell by harnessing the cell’s own degradation machinery. In a new study, researchers at CeMM, AITHYRA and the Scripps Research Institute have now developed a systematic method to discover such protein-degrading compounds on a large scale. The approach, published in Nature Chemical Biology (DOI: 10.1038/s41589-025-02137-2) provides a powerful new route toward therapies for diseases such as certain aggressive forms of leukemia.Many diseases are driven by proteins that are difficult or impossible to inhibit with conventional drugs. Instead of blocking their activity, an emerging therapeutic strategy aims to remove these proteins entirely from the cell by harnessing the cell’s own degradation machinery. In a new study, researchers at CeMM, AITHYRA and the Scripps Research Institute have now developed a systematic method to discover such protein-degrading compounds on a large scale. The approach, published in Nature Chemical Biology (DOI: 10.1038/s41589-025-02137-2) provides a powerful new route toward therapies for diseases such as certain aggressive forms of leukemia.